Your session is about to expire
← Back to Search
STEGA-MRI for Brain Connectivity in Hand Movement
N/A
Recruiting
Led By Benjamin A Philip, PhD
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Able to fit in Prisma scanner bore (60 cm diameter)
Age ≥ 18
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1
Awards & highlights
Study Summary
This trial is testing if certain areas of the brain are necessary for skilled left-handed movement.
Who is the study for?
This trial is for adults over 18 who primarily use their right hand, speak and read English, can fit in an MRI machine, and have had a chronic nerve injury on the right side for at least 6 months. It's not suitable for those who don't meet these specific conditions.Check my eligibility
What is being tested?
The study uses STEGA-MRI to explore how the brain adapts to allow skillful movement of the left non-dominant hand after a person has suffered from a peripheral nerve injury on the right side.See study design
What are the potential side effects?
Since this trial involves MRI imaging (STEGA-MRI), there are generally no direct physical side effects expected. However, individuals may experience discomfort or claustrophobia inside the scanner.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can fit into a 60 cm wide scanner.
Select...
I am 18 years old or older.
Select...
I have a long-term nerve injury in my right arm.
Select...
My hand function is significantly lower than average for my age.
Select...
My injury is due to a specific cause like pressure or a tumor.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 1
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
BOLD (blood oxygen level dependent) signal in ROIs (regions of interest)
Secondary outcome measures
Drawing smoothness
Hand choice
Trial Design
1Treatment groups
Experimental Treatment
Group I: Movement taskExperimental Treatment1 Intervention
All participants perform the STEGA-MRI (standardized tracing evaluation & grapheme assessment - MRI) precision drawing task during fMRI scanning.
Motor assessments outside the MRI do not qualify as interventions.
Find a Location
Who is running the clinical trial?
Washington University School of MedicineLead Sponsor
1,942 Previous Clinical Trials
2,304,143 Total Patients Enrolled
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,346 Previous Clinical Trials
650,611 Total Patients Enrolled
Benjamin A Philip, PhDPrincipal InvestigatorWashington University School of Medicine
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My condition involves my hand, arm, or shoulder.I can fit into a 60 cm wide scanner.My injury occurred over 6 months ago.I may be excluded from certain parts of the study but not necessarily the whole study.I have had an amputation of part or all of my thumb, index, or middle finger.I am 18 years old or older.I have a condition affecting my right hand that is not due to nerve injury.I have had issues with my left hand's movement in the last 2 years.I have a long-term nerve injury in my right arm.I have a history of a major neurological condition like stroke or Alzheimer's.I have been diagnosed with schizophrenia or a rare psychiatric disorder.I have had issues with hand movement in the last 2 years.I had surgery on my arm or hand in the last 2 months.I have chronic pain not caused by nerve injury.I have not had a concussion in the last 6 months or suffer from post-concussion syndrome.My hand function is significantly lower than average for my age.I can speak and read English.My injury is due to a specific cause like pressure or a tumor.
Research Study Groups:
This trial has the following groups:- Group 1: Movement task
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the upper limit of participants for this medical experiment?
"Affirmative. The clinicaltrials.gov database reveals that this scientific inquiry, which was initially announced on December 9th 2021, is currently recruiting patients. A total of 147 participants must be enlisted from 1 research centre."
Answered by AI
Are there any remaining openings for participants in this experiment?
"Affirmative. Per the information available on clinicaltrials.gov, this experiment is currently seeking recruits. It was first announced on December 9th 2021 and updated most recently in January 11th 2022. This research wants to include 147 patients from 1 trial location."
Answered by AI
Who else is applying?
What state do they live in?
Missouri
How old are they?
18 - 65
What site did they apply to?
Washington University School of Medicine
What portion of applicants met pre-screening criteria?
Met criteria
How responsive is this trial?
Typically responds via
Phone Call
Most responsive sites:
- Washington University School of Medicine: < 48 hours
Average response time
- < 2 Days
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger